ANIP logo

ANI Pharmaceuticals (ANIP) Current liabilities

annual current liabilities:

$193.68M+$48.20M(+33.13%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual total current liabilities is $193.68 million, with the most recent change of +$48.20 million (+33.13%) on December 31, 2024.
  • During the last 3 years, ANIP annual current liabilities has risen by +$106.14 million (+121.26%).
  • ANIP annual current liabilities is now at all-time high.

Performance

ANIP Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPbalance sheet metrics

quarterly current liabilities:

$201.81M+$8.13M(+4.20%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly total current liabilities is $201.81 million, with the most recent change of +$8.13 million (+4.20%) on March 31, 2025.
  • Over the past year, ANIP quarterly current liabilities has increased by +$64.93 million (+47.43%).
  • ANIP quarterly current liabilities is now at all-time high.

Performance

ANIP quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

ANIP Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+33.1%+47.4%
3 y3 years+121.3%+153.8%
5 y5 years+214.0%+154.3%

ANIP Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+121.3%at high+153.8%
5 y5-yearat high+214.0%at high+165.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

ANIP Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$201.81M(+4.2%)
Dec 2024
$193.68M(+33.1%)
$193.68M(+2.0%)
Sep 2024
-
$189.93M(+35.7%)
Jun 2024
-
$139.98M(+2.3%)
Mar 2024
-
$136.89M(-5.9%)
Dec 2023
$145.48M(+46.3%)
$145.48M(+8.3%)
Sep 2023
-
$134.35M(+9.3%)
Jun 2023
-
$122.86M(-2.4%)
Mar 2023
-
$125.83M(+26.5%)
Dec 2022
$99.44M(+13.6%)
$99.44M(+21.8%)
Sep 2022
-
$81.63M(-15.2%)
Jun 2022
-
$96.31M(+21.1%)
Mar 2022
-
$79.53M(-9.1%)
Dec 2021
$87.54M(+11.4%)
$87.54M(+3.1%)
Sep 2021
-
$84.87M(-5.1%)
Jun 2021
-
$89.45M(+8.1%)
Mar 2021
-
$82.77M(+5.3%)
Dec 2020
$78.56M(+27.4%)
$78.56M(+3.5%)
Sep 2020
-
$75.90M(-4.0%)
Jun 2020
-
$79.09M(-0.3%)
Mar 2020
-
$79.36M(+28.7%)
Dec 2019
$61.68M(-62.7%)
$61.68M(-63.9%)
Sep 2019
-
$170.71M(+2.3%)
Jun 2019
-
$166.79M(+1.0%)
Mar 2019
-
$165.07M(-0.3%)
Dec 2018
$165.55M(+322.0%)
$165.55M(+253.0%)
Sep 2018
-
$46.90M(+18.2%)
Jun 2018
-
$39.68M(+0.1%)
Mar 2018
-
$39.65M(+1.1%)
Dec 2017
$39.23M(+22.8%)
$39.23M(+7.8%)
Sep 2017
-
$36.38M(+28.6%)
Jun 2017
-
$28.29M(-12.7%)
Mar 2017
-
$32.42M(+1.5%)
Dec 2016
$31.95M(+171.8%)
$31.95M(+4.8%)
Sep 2016
-
$30.49M(+23.3%)
Jun 2016
-
$24.73M(+52.6%)
Mar 2016
-
$16.21M(+37.9%)
Dec 2015
$11.76M(-11.2%)
$11.76M(-3.6%)
Sep 2015
-
$12.19M(+75.4%)
Jun 2015
-
$6.95M(-23.4%)
Mar 2015
-
$9.07M(-31.4%)
Dec 2014
$13.23M(+274.0%)
$13.23M(+62.5%)
Sep 2014
-
$8.14M(+112.8%)
Jun 2014
-
$3.83M(-16.1%)
Mar 2014
-
$4.56M(+28.9%)
Dec 2013
$3.54M(-66.6%)
$3.54M(-46.4%)
Sep 2013
-
$6.60M(+7.0%)
Jun 2013
-
$6.16M(-33.9%)
Mar 2013
-
$9.33M(-12.0%)
Dec 2012
$10.59M
$10.59M(-3.0%)
Sep 2012
-
$10.92M(-33.3%)
DateAnnualQuarterly
Jun 2012
-
$16.37M(+169.1%)
Mar 2012
-
$6.08M(-15.8%)
Dec 2011
$7.23M(-11.7%)
$7.23M(-37.1%)
Sep 2011
-
$11.50M(+0.2%)
Jun 2011
-
$11.48M(-9.1%)
Mar 2011
-
$12.63M(+54.4%)
Dec 2010
$8.18M(+108.2%)
$8.18M(+15.3%)
Sep 2010
-
$7.10M(+6.1%)
Jun 2010
-
$6.69M(+7.5%)
Mar 2010
-
$6.22M(+58.4%)
Dec 2009
$3.93M(+2.0%)
$3.93M(-17.7%)
Sep 2009
-
$4.78M(+28.5%)
Jun 2009
-
$3.72M(+19.7%)
Mar 2009
-
$3.10M(-19.4%)
Dec 2008
$3.85M(+154.2%)
$3.85M(-15.7%)
Sep 2008
-
$4.57M(+26.2%)
Jun 2008
-
$3.62M(+23.7%)
Mar 2008
-
$2.93M(+93.1%)
Dec 2007
$1.52M(-64.7%)
$1.52M(-32.2%)
Sep 2007
-
$2.23M(-14.4%)
Jun 2007
-
$2.61M(+7.4%)
Mar 2007
-
$2.43M(-43.5%)
Dec 2006
$4.30M(+61.3%)
$4.30M(+158.5%)
Sep 2006
-
$1.66M(-27.8%)
Jun 2006
-
$2.30M(-15.8%)
Mar 2006
-
$2.73M(+2.6%)
Dec 2005
$2.67M(+39.8%)
$2.67M(+77.2%)
Sep 2005
-
$1.50M(-3.0%)
Jun 2005
-
$1.55M(-14.4%)
Mar 2005
-
$1.81M(-5.0%)
Dec 2004
$1.91M(+116.4%)
$1.91M(+42.7%)
Sep 2004
-
$1.34M(+13.6%)
Jun 2004
-
$1.18M(+2.6%)
Mar 2004
-
$1.15M(+30.1%)
Dec 2003
$881.20K(-29.9%)
$881.20K(+25.9%)
Sep 2003
-
$700.10K(-2.8%)
Jun 2003
-
$720.60K(+29.9%)
Mar 2003
-
$554.90K(-55.8%)
Dec 2002
$1.26M(+35.4%)
$1.26M(+81.3%)
Sep 2002
-
$692.80K(-5.8%)
Jun 2002
-
$735.70K(+8.5%)
Mar 2002
-
$678.20K(-26.9%)
Dec 2001
$927.80K(-1.4%)
$927.80K(-9.8%)
Sep 2001
-
$1.03M(+9.4%)
Jun 2001
-
$940.70K(+18.4%)
Mar 2001
-
$794.50K(-15.6%)
Dec 2000
$941.30K(+186.0%)
$941.30K(+35.0%)
Sep 2000
-
$697.30K(+182.1%)
Jun 2000
-
$247.20K(-13.7%)
Mar 2000
-
$286.30K
Dec 1999
$329.10K(-59.8%)
-
Dec 1998
$817.90K
-

FAQ

  • What is ANI Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual current liabilities year-on-year change?
  • What is ANI Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly current liabilities year-on-year change?

What is ANI Pharmaceuticals annual total current liabilities?

The current annual current liabilities of ANIP is $193.68M

What is the all time high annual current liabilities for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual total current liabilities is $193.68M

What is ANI Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, ANIP annual total current liabilities has changed by +$48.20M (+33.13%)

What is ANI Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of ANIP is $201.81M

What is the all time high quarterly current liabilities for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly total current liabilities is $201.81M

What is ANI Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, ANIP quarterly total current liabilities has changed by +$64.93M (+47.43%)
On this page